CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 189 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02090803
NCT02090803N/ACompleted
CompareCT.gov

Assessment of Human Herpes Virus Reactivation 6 Post Autologous Stem Cells , Prospective, Open, Multicenter Study

Institut de Cancérologie de la Loire·observational·Posted Mar 18, 2014·Updated Sep 14, 2017

In Brief

An observational study for Hematologic Diseases. Completed, enrolled 189 participants across 3 sites.

Detailed Summary

The purpose of this study is to assess the human herpes virus reactivation 6 post autologous stem cells in 196 patients. The aim of our study was to describe the incidence of reactivation of HHV-6 in patients requiring autologous HSCT and determine the pathogenic role in this target population.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsHematologic Diseases
CountriesFrance
Collaborators--

Timeline

N/ACompletedFinished
20132014201520162017201820192020202120222023202420252026
First PostedMar 18, 2014
Enrollment StartAug 1, 2012
Primary CompletionMar 1, 2015
TodayJul 2, 2026
Enrollment to primary: 2.6 yearsPosted 12.3 years ago